Custom Lentivirus Production Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510248375

Publication Date:

October 11, 2024

Pages:

145

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Custom Lentivirus Production Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Custom Lentivirus Production Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Lentivirus Production Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Custom Lentivirus Production Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Custom Lentivirus Production Services include LipExoGen Biotech, OriGene Technologies, Kerafast, Applied Biological Materials(abm), GeneCopoeia, Cellomics Technology, Charles River Laboratories, AMSBIO and Genemedi Suzhou Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Custom Lentivirus Production Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Custom Lentivirus Production Services by region & country, by Type, and by Application.
The Custom Lentivirus Production Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Lentivirus Production Services.
麻豆原创 Segmentation
By Company
LipExoGen Biotech
OriGene Technologies
Kerafast
Applied Biological Materials(abm)
GeneCopoeia
Cellomics Technology
Charles River Laboratories
AMSBIO
Genemedi Suzhou Biotechnology
BPS Bioscience
Cellecta
VectorBuilder
Creative Biogene
Sigma-Aldrich
System Biosciences
Thermo Fisher Scientific
Addgene
Gentarget
BioCat GmbH
ProMab
Excellgen
Capital Biosciences
Hanheng Biotechnology (Shanghai)
Segment by Type:
Lentiviral Plasmids
Lentiviral Particles
Segment by Application
Biological
Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Custom Lentivirus Production Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Custom Lentivirus Production Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Custom Lentivirus Production Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Custom Lentivirus Production Services Product Introduction
1.2 Global Custom Lentivirus Production Services 麻豆原创 Size Forecast
1.3 Custom Lentivirus Production Services 麻豆原创 Trends & Drivers
1.3.1 Custom Lentivirus Production Services Industry Trends
1.3.2 Custom Lentivirus Production Services 麻豆原创 Drivers & Opportunity
1.3.3 Custom Lentivirus Production Services 麻豆原创 Challenges
1.3.4 Custom Lentivirus Production Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Custom Lentivirus Production Services Players Revenue Ranking (2023)
2.2 Global Custom Lentivirus Production Services Revenue by Company (2019-2024)
2.3 Key Companies Custom Lentivirus Production Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Custom Lentivirus Production Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Custom Lentivirus Production Services
2.6 Custom Lentivirus Production Services 麻豆原创 Competitive Analysis
2.6.1 Custom Lentivirus Production Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Custom Lentivirus Production Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Lentivirus Production Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Lentiviral Plasmids
3.1.2 Lentiviral Particles
3.2 Global Custom Lentivirus Production Services Sales Value by Type
3.2.1 Global Custom Lentivirus Production Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Custom Lentivirus Production Services Sales Value, by Type (2019-2030)
3.2.3 Global Custom Lentivirus Production Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biological
4.1.2 Medical
4.2 Global Custom Lentivirus Production Services Sales Value by Application
4.2.1 Global Custom Lentivirus Production Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Custom Lentivirus Production Services Sales Value, by Application (2019-2030)
4.2.3 Global Custom Lentivirus Production Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Custom Lentivirus Production Services Sales Value by Region
5.1.1 Global Custom Lentivirus Production Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Custom Lentivirus Production Services Sales Value by Region (2019-2024)
5.1.3 Global Custom Lentivirus Production Services Sales Value by Region (2025-2030)
5.1.4 Global Custom Lentivirus Production Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Custom Lentivirus Production Services Sales Value, 2019-2030
5.2.2 North America Custom Lentivirus Production Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Custom Lentivirus Production Services Sales Value, 2019-2030
5.3.2 Europe Custom Lentivirus Production Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Custom Lentivirus Production Services Sales Value, 2019-2030
5.4.2 Asia Pacific Custom Lentivirus Production Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Custom Lentivirus Production Services Sales Value, 2019-2030
5.5.2 South America Custom Lentivirus Production Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Custom Lentivirus Production Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Custom Lentivirus Production Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Custom Lentivirus Production Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Custom Lentivirus Production Services Sales Value
6.3 United States
6.3.1 United States Custom Lentivirus Production Services Sales Value, 2019-2030
6.3.2 United States Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Custom Lentivirus Production Services Sales Value, 2019-2030
6.4.2 Europe Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Custom Lentivirus Production Services Sales Value, 2019-2030
6.5.2 China Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Custom Lentivirus Production Services Sales Value, 2019-2030
6.6.2 Japan Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Custom Lentivirus Production Services Sales Value, 2019-2030
6.7.2 South Korea Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Custom Lentivirus Production Services Sales Value, 2019-2030
6.8.2 Southeast Asia Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Custom Lentivirus Production Services Sales Value, 2019-2030
6.9.2 India Custom Lentivirus Production Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Custom Lentivirus Production Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LipExoGen Biotech
7.1.1 LipExoGen Biotech Profile
7.1.2 LipExoGen Biotech Main Business
7.1.3 LipExoGen Biotech Custom Lentivirus Production Services Products, Services and Solutions
7.1.4 LipExoGen Biotech Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.1.5 LipExoGen Biotech Recent Developments
7.2 OriGene Technologies
7.2.1 OriGene Technologies Profile
7.2.2 OriGene Technologies Main Business
7.2.3 OriGene Technologies Custom Lentivirus Production Services Products, Services and Solutions
7.2.4 OriGene Technologies Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.2.5 OriGene Technologies Recent Developments
7.3 Kerafast
7.3.1 Kerafast Profile
7.3.2 Kerafast Main Business
7.3.3 Kerafast Custom Lentivirus Production Services Products, Services and Solutions
7.3.4 Kerafast Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.3.5 Applied Biological Materials(abm) Recent Developments
7.4 Applied Biological Materials(abm)
7.4.1 Applied Biological Materials(abm) Profile
7.4.2 Applied Biological Materials(abm) Main Business
7.4.3 Applied Biological Materials(abm) Custom Lentivirus Production Services Products, Services and Solutions
7.4.4 Applied Biological Materials(abm) Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.4.5 Applied Biological Materials(abm) Recent Developments
7.5 GeneCopoeia
7.5.1 GeneCopoeia Profile
7.5.2 GeneCopoeia Main Business
7.5.3 GeneCopoeia Custom Lentivirus Production Services Products, Services and Solutions
7.5.4 GeneCopoeia Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.5.5 GeneCopoeia Recent Developments
7.6 Cellomics Technology
7.6.1 Cellomics Technology Profile
7.6.2 Cellomics Technology Main Business
7.6.3 Cellomics Technology Custom Lentivirus Production Services Products, Services and Solutions
7.6.4 Cellomics Technology Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.6.5 Cellomics Technology Recent Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Profile
7.7.2 Charles River Laboratories Main Business
7.7.3 Charles River Laboratories Custom Lentivirus Production Services Products, Services and Solutions
7.7.4 Charles River Laboratories Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.7.5 Charles River Laboratories Recent Developments
7.8 AMSBIO
7.8.1 AMSBIO Profile
7.8.2 AMSBIO Main Business
7.8.3 AMSBIO Custom Lentivirus Production Services Products, Services and Solutions
7.8.4 AMSBIO Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.8.5 AMSBIO Recent Developments
7.9 Genemedi Suzhou Biotechnology
7.9.1 Genemedi Suzhou Biotechnology Profile
7.9.2 Genemedi Suzhou Biotechnology Main Business
7.9.3 Genemedi Suzhou Biotechnology Custom Lentivirus Production Services Products, Services and Solutions
7.9.4 Genemedi Suzhou Biotechnology Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.9.5 Genemedi Suzhou Biotechnology Recent Developments
7.10 BPS Bioscience
7.10.1 BPS Bioscience Profile
7.10.2 BPS Bioscience Main Business
7.10.3 BPS Bioscience Custom Lentivirus Production Services Products, Services and Solutions
7.10.4 BPS Bioscience Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.10.5 BPS Bioscience Recent Developments
7.11 Cellecta
7.11.1 Cellecta Profile
7.11.2 Cellecta Main Business
7.11.3 Cellecta Custom Lentivirus Production Services Products, Services and Solutions
7.11.4 Cellecta Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.11.5 Cellecta Recent Developments
7.12 VectorBuilder
7.12.1 VectorBuilder Profile
7.12.2 VectorBuilder Main Business
7.12.3 VectorBuilder Custom Lentivirus Production Services Products, Services and Solutions
7.12.4 VectorBuilder Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.12.5 VectorBuilder Recent Developments
7.13 Creative Biogene
7.13.1 Creative Biogene Profile
7.13.2 Creative Biogene Main Business
7.13.3 Creative Biogene Custom Lentivirus Production Services Products, Services and Solutions
7.13.4 Creative Biogene Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.13.5 Creative Biogene Recent Developments
7.14 Sigma-Aldrich
7.14.1 Sigma-Aldrich Profile
7.14.2 Sigma-Aldrich Main Business
7.14.3 Sigma-Aldrich Custom Lentivirus Production Services Products, Services and Solutions
7.14.4 Sigma-Aldrich Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.14.5 Sigma-Aldrich Recent Developments
7.15 System Biosciences
7.15.1 System Biosciences Profile
7.15.2 System Biosciences Main Business
7.15.3 System Biosciences Custom Lentivirus Production Services Products, Services and Solutions
7.15.4 System Biosciences Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.15.5 System Biosciences Recent Developments
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Profile
7.16.2 Thermo Fisher Scientific Main Business
7.16.3 Thermo Fisher Scientific Custom Lentivirus Production Services Products, Services and Solutions
7.16.4 Thermo Fisher Scientific Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.16.5 Thermo Fisher Scientific Recent Developments
7.17 Addgene
7.17.1 Addgene Profile
7.17.2 Addgene Main Business
7.17.3 Addgene Custom Lentivirus Production Services Products, Services and Solutions
7.17.4 Addgene Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.17.5 Addgene Recent Developments
7.18 Gentarget
7.18.1 Gentarget Profile
7.18.2 Gentarget Main Business
7.18.3 Gentarget Custom Lentivirus Production Services Products, Services and Solutions
7.18.4 Gentarget Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.18.5 Gentarget Recent Developments
7.19 BioCat GmbH
7.19.1 BioCat GmbH Profile
7.19.2 BioCat GmbH Main Business
7.19.3 BioCat GmbH Custom Lentivirus Production Services Products, Services and Solutions
7.19.4 BioCat GmbH Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.19.5 BioCat GmbH Recent Developments
7.20 ProMab
7.20.1 ProMab Profile
7.20.2 ProMab Main Business
7.20.3 ProMab Custom Lentivirus Production Services Products, Services and Solutions
7.20.4 ProMab Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.20.5 ProMab Recent Developments
7.21 Excellgen
7.21.1 Excellgen Profile
7.21.2 Excellgen Main Business
7.21.3 Excellgen Custom Lentivirus Production Services Products, Services and Solutions
7.21.4 Excellgen Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.21.5 Excellgen Recent Developments
7.22 Capital Biosciences
7.22.1 Capital Biosciences Profile
7.22.2 Capital Biosciences Main Business
7.22.3 Capital Biosciences Custom Lentivirus Production Services Products, Services and Solutions
7.22.4 Capital Biosciences Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.22.5 Capital Biosciences Recent Developments
7.23 Hanheng Biotechnology (Shanghai)
7.23.1 Hanheng Biotechnology (Shanghai) Profile
7.23.2 Hanheng Biotechnology (Shanghai) Main Business
7.23.3 Hanheng Biotechnology (Shanghai) Custom Lentivirus Production Services Products, Services and Solutions
7.23.4 Hanheng Biotechnology (Shanghai) Custom Lentivirus Production Services Revenue (US$ Million) & (2019-2024)
7.23.5 Hanheng Biotechnology (Shanghai) Recent Developments
8 Industry Chain Analysis
8.1 Custom Lentivirus Production Services Industrial Chain
8.2 Custom Lentivirus Production Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Custom Lentivirus Production Services Sales Model
8.5.2 Sales Channel
8.5.3 Custom Lentivirus Production Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

LipExoGen Biotech
OriGene Technologies
Kerafast
Applied Biological Materials(abm)
GeneCopoeia
Cellomics Technology
Charles River Laboratories
AMSBIO
Genemedi Suzhou Biotechnology
BPS Bioscience
Cellecta
VectorBuilder
Creative Biogene
Sigma-Aldrich
System Biosciences
Thermo Fisher Scientific
Addgene
Gentarget
BioCat GmbH
ProMab
Excellgen
Capital Biosciences
Hanheng Biotechnology (Shanghai)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.